$30.25
0[0.00%]
At close: May 9
$30.25
0[0.00%]
PreMarket: 4:00PM EDT
Omnicell
(NASDAQ:OMCL)Latest News for Omnicell Stock (NASDAQ:OMCL)
Omnicell Stock (NASDAQ: OMCL)
Categories: All
Friday, May 03, 2024
Thursday, May 02, 2024
- Omnicell Reaffirms FY24 Outlook: Adj EPS $0.90-1.40 vs $1.07 Est; Sees Sales $1.045B-1.120B vs $1.06B EstBenzinga Newsdesk - May 2, 2024, 7:47AM
- Omnicell Q2 Outlook: Total Revenues $250M - $260M Vs. $261.88M Estimate, Adj. EPS $0.10-$0.20 Vs. $0.27 EstimateBenzinga Newsdesk - May 2, 2024, 7:42AM
- Omnicell Q1 2024 Adj EPS $0.03 Beats $(0.09) Estimate, Sales $246.150M Beat $236.754M EstimateBenzinga Newsdesk - May 2, 2024, 7:37AM
Tuesday, April 30, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
- Omnicell shares are trading lower after the company reported fourth-quarter financial results and issued guidance below estimates.Benzinga Newsdesk - Feb 8, 2024, 8:08AM
- Omnicell Expects Q1 Revenue of $232M-$242M Vs $262.37M Est, Adj EPS of ($0.10)-$0.00 Vs $0.31 Est, FY24 Revenue of $1.045B-$1.120B Vs $1.08B Est, Adj EPS of $0.90-$1.40 Vs $1.66 EstBenzinga Newsdesk - Feb 8, 2024, 8:05AM
- Omnicell Q4 Adj EPS $0.33 Beats $0.15 Estimate, Sales $258.85M Beat $255.56M EstimateBenzinga Newsdesk - Feb 8, 2024, 8:02AM
- Earnings Scheduled For February 8, 2024Benzinga Insights - Feb 8, 2024, 4:43AM
Friday, November 03, 2023
- Piper Sandler Upgrades Omnicell: Here's What You Need To KnowBenzinga Insights - Nov 3, 2023, 1:00PM
- Wells Fargo Upgrades Omnicell to Equal-Weight, Lowers Price Target to $28Benzinga Newsdesk - Nov 3, 2023, 8:04AM
- BTIG Downgrades Omnicell to NeutralBenzinga Newsdesk - Nov 3, 2023, 4:39AM
- Piper Sandler Upgrades Omnicell to Overweight, Lowers Price Target to $39Benzinga Newsdesk - Nov 3, 2023, 4:33AM
Thursday, November 02, 2023
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- Omnicell Announces Headcount Reduction, Expects $12M-$18M In Non-Recurring CostsBenzinga Newsdesk - Nov 2, 2023, 8:39AM
- Omnicell Sees Q4 2023 Revenue $247M-$267M Vs $299.67M EstBenzinga Newsdesk - Nov 2, 2023, 8:38AM
- Omnicell Sees FY23 Bookings $850M-$950M, Sees Revenues $1.135B-$1.155B EstimateBenzinga Newsdesk - Nov 2, 2023, 8:38AM
- Omnicell Q3 2023 Adj. EPS $0.62 Beats $0.47 Estimate, Revenue $299M Beats $295.47M EstimateBenzinga Newsdesk - Nov 2, 2023, 8:05AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, October 11, 2023
Wednesday, October 04, 2023
Tuesday, October 03, 2023
Tuesday, September 26, 2023
Wednesday, August 30, 2023
Friday, August 04, 2023
Wednesday, August 02, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023Benzinga Insights - Aug 2, 2023, 11:00AM
- Benchmark Reiterates Buy on Omnicell, Maintains $88 Price TargetBenzinga Newsdesk - Aug 2, 2023, 10:30AM
- Piper Sandler Downgrades Omnicell to Neutral, Raises Price Target to $70Benzinga Newsdesk - Aug 2, 2023, 6:35AM
Tuesday, August 01, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Aug 1, 2023, 5:32PM
- Omnicell Q2 Adj EPS $0.57 Beats $0.28 Estimate, Sales $298.97M Beat $284.57M EstimateBenzinga Newsdesk - Aug 1, 2023, 4:04PM
- Earnings Scheduled For August 1, 2023Benzinga Insights - Aug 1, 2023, 4:06AM